Development of a biomimetic nanoparticle platform for apigenin therapy in triple-negative breast cancer

Development of a biomimetic nanoparticle platform for apigenin therapy in triple-negative breast cancer

BackgroundThis study investigates the therapeutic potential and mechanisms of Apigenin (AGN) in treating triple-negative breast cancer (TNBC). Although AGN is recognized for its anti-tumor properties, its specific mechanisms in TNBC remain unclear.MethodsTo identify key genes associated with AGN’s e...

Full description

Saved in:
Bibliographic Details
Main Authors: Chenyang Wang, Xiaojing Ren, Yanmei Han, Ding Nan, Yajing Zhang, Zairong Gao
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Oncology
Subjects:
breast cancer
network pharmacology
apigenin
biomimetic nanomaterials
immune evasion and tumor targeting
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1521529/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2025.1521529/full

Similar Items